Transdermal Type I Collagen is manufactured via pharmaceutical-grade synthetic biology, delivering 100% human-homologous full-length active Type I collagen integrated with Mellgen's 3rd-generation transdermal technology, completely transcending the superficial surface film-forming limitations of conventional collagens.
As the primary structural scaffolding protein of the dermis, it directly supplements depleted collagen fibers to counter photoaging and natural chronological breakdown. It significantly bolsters dermal tensile strength and facial contour firmness, locking in moisture to restore bouncy, supple, and refined youthful skin.
Transdermal Model
Type I transdermal collagen deep penetration and dermal fibril network reinforcement.
RAW MATERIAL TECHNICAL & REGULATORY DOSSIER
Comprehensive Technical, Quality Specification, and Regulatory Dossier for R&D Formulators, Procurement, and Product Managers
📊
Biotechnology Mechanism & Scientific Evidence
Authoritative Brochure Technical Diagram · Molecular Model · Transdermal & Efficacy Mechanism
Mechanism DiagramTransdermal Type I recombinant collagen penetrating to dermis via 3rd-gen delivery pathway.
🔬
Formulation R&D Engineer Guide (R&D Technical Dossier)
Formulation Application · Physicochemical Parameters · Stability & Compatibility
| INCI Name (CN) |
Collagen, Decapeptide-4、1,2-1,2-Hexanediol, Aqua |
INCI Name (EN) |
Collagen, Decapeptide-4, 1,2-Hexanediol, Aqua |
| CAS No. |
9007-34-5 / 917094-11-2 / 6920-22-5 / 7732-18-5 |
Recommended Dosage |
0.3% - 3.0% (Recommended 0.5% - 1.5% for deep anti-aging) |
| Optimal pH Range |
5.5 - 7.5 |
Thermal Processing |
Add below 45°C during the cooling stage; avoid intense shearing |
| Appearance & Odor |
Colorless to pale yellowish clear liquid |
Solubility & Method |
Fully water-soluble, excellent dispersion |
💡 Compatibility Guidelines & Precautions: Highly compatible with hyaluronic acid, peptides, and standard cosmetic emulsion systems
📦
Procurement & Compliance Dossier (Procurement & Compliance)
NMPA Code · MOQ · Sampling Support · Certificate of Analysis
| NMPA Submission Code |
✓ 218266-00075-7345 |
Supply Packaging |
1 kg/bottle, 5 kg/drum, 25 kg/drum |
| Minimum Order Quantity (MOQ) |
1 kg (In stock) |
Delivery Lead Time |
Dispatched within 24-48 hours |
| Storage Conditions |
Store sealed at 2-8°C away from light in dry conditions |
Shelf Life (Shelf Life) |
24 months |
| R&D Sample Support |
Free 30g testing sample and formulation guidelines available |
Quality Documentation |
Batch COA, MSDS, SPEC, and heavy metal/microbial compliance reports |
💡
Product Planning & Marketing Highlights (Marketing Highlights)
Core Mechanism · Efficacy Claims · Recommended Formats · Scientific Backing
🧬 Core Bio-Tech Barrier & Mechanism of Action:
Integrated with proprietary transdermal peptide carrier, 100% recombinant human Type I collagen directly supplements the primary structural collagen matrix of the dermis, preventing age-related collagen depletion.
✨ Key Selling Point Keywords:
🏷️ 100% Recombinant Human Type I Collagen🏷️ Transdermal Fusion Tech🏷️ Direct Dermal Replenishment🏷️ Repairing🏷️ Anti-aging🏷️ Firming
🧴 Recommended Product Formats & Categories:
Anti-aging firming serums, collagen plumping creams, post-treatment ampoules, elastic sheet masks
📜 Patented Technologies & Scientific Backing:
Chinese Invention Patent (Patent No.: ZL202410492632.8)
⚖️
Regulatory Compliance & Peer-to-Peer Disclaimer
Regulatory Compliance & Technical Disclaimer:
1. The raw material technical data, cellular mechanism studies, and performance specifications presented on this page are intended exclusively for professional B2B exchange, cosmetic R&D formulators, product planners, and academic institutions. They do not constitute consumer-facing cosmetic claims or commercial warranties.
2. In accordance with applicable cosmetic regulations, finished cosmetic brand owners and manufacturing partners are responsible for evaluating finished product safety, stability, and efficacy validation before market launch and regulatory filing.
3. Mellgen Biotechnology assumes no legal liability for any non-compliant efficacy claims or misuse of finished products by downstream partners.
